Collecting data on proton therapy for cancer treatment
Advanced Proton Therapy Approaches: a Multicenter High-quality Data Registry
European Institute of Oncology · NCT05860361
This study is collecting information on how well proton therapy works for cancer treatment to help improve care for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | European Institute of Oncology (other) |
| Locations | 1 site (Milan) |
| Trial ID | NCT05860361 on ClinicalTrials.gov |
What this trial studies
This registry aims to prospectively gather high-quality data on patients undergoing proton therapy for various oncological conditions. It focuses on understanding the feasibility and clinical outcomes of hypofractionated treatment schedules. The study will implement a three-level data collection approach, including clinical outcomes, radiological analysis, and biological research. By addressing the current lack of robust evidence in proton therapy, this registry seeks to enhance knowledge and improve treatment protocols.
Who should consider this trial
Good fit: Ideal candidates include patients with any type of oncological disease who are eligible for proton therapy.
Not a fit: Patients under 18 years of age will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment strategies and outcomes for cancer patients receiving proton therapy.
How similar studies have performed: While there is limited data on proton therapy, similar registries have shown promise in enhancing treatment understanding and outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * diagnosis of oncological disease (benign and malignant disease); * candidates to proton therapy; * able to provide informed consent. Exclusion criteria: \- age \< 18 years.
Where this trial is running
Milan
- European Institute of Oncology — Milan, Italy (RECRUITING)
Study contacts
- Principal investigator: Roberto Orecchia — European Institute of Oncology
- Study coordinator: Roberto Orecchia, Prof
- Email: roberto.orecchia@ieo.it
- Phone: +39 0257489578
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, proton therapy, registry, high-quality dataset, prospective data collection, hypofractionation